OnCo
companiesCompany

Oxford Nanopore Technologies

Portable and high-throughput nanopore sequencing, used for rapid intraoperative brain-tumour classification and structural variant detection.

MinION, GridION, PromethION; real-time methylation calling enables sub-hour CNS tumour classification (Rapid-CNS2); clinical-grade Q20+ chemistry since 2023.

Headquarters
Oxford, GB
Type
diagnostics · ONT.L

Connected

3top

Pages like this

not linked directly; found by shared links